Prostate MRI and 3D MR spectroscopy: How we do it

American Journal of Roentgenology

Volumn 194, Issue 6, 2010, Pages 1414-1426

  Verma, Sadhna ^a   Rajesh, Arumugam ^b   Fütterer, Jurgen J ^c   Turkbey, Baris ^d   Scheenen, Tom W J ^c   Pang, Yuxi ^d   Choyke, Peter L ^d   Kurhanewicz, John ^e  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b LEICESTER GENERAL HOSPITAL   (United Kingdom)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d NATIONAL CANCER INSTITUTE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Choline; Citrate; Metabolites; MR spectroscopy; MRI; Oncologic imaging; Polyamines; Prostate; Prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; CHOLINE; CITRIC ACID; CREATINE; POLYAMINE;

DIAGNOSTIC ACCURACY; GLEASON SCORE; HUMAN; IMAGE PROCESSING; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; THREE DIMENSIONAL IMAGING; CANCER STAGING; COMPUTER ASSISTED DIAGNOSIS; DIFFERENTIAL DIAGNOSIS; IMAGE ENHANCEMENT; INSTRUMENTATION; LIPID METABOLISM; MALE; METHODOLOGY; PATHOLOGY; PROSTATE TUMOR;

CHOLINE; CITRATES; CREATINE; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; LIPID METABOLISM; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NEOPLASM STAGING; POLYAMINES; PROSTATIC NEOPLASMS;

EID: 77953264918     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.10.4312     Document Type: Review

References (35)

1. Heijmink SW, Futterer JJ, Hambrock T, et al. Prostate cancer: body-array versus endorectal coil MR imaging at 3 T - comparison of image quality, localization, and staging performance. Radiology 2007; 244:184-195
2. Qayyum A, Coakley FV, Lu Y, et al. Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging. AJR 2004; 183:1079-1083
3. Brown TR, Kincaid BM, Ugurbil K. NMR chemical shift imaging in three dimensions. Proc Natl Acad Sci USA 1982; 79:3523-3526
4. 1H MR spectroscopy. RadioGraphics 2004; 24[suppl 1]:S167-S180
5. Coakley FV, Kurhanewicz J, Lu Y, et al. Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. Radiology 2002; 223:91-97
6. Hricak H. MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer. Br J Radiol 2005; 78(spec no 2):S103-S111
7. Kurhanewicz J, Vigneron DB, Hricak H, Narayan P, Carroll P, Nelson SJ. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. Radiology 1996; 198:795-805
8. Scheenen TW, Klomp DW, Roll SA, Fütterer JJ, Barentsz JO, Heerschap A. Fast acquisition-weighted three-dimensional proton MR spectroscopic imaging of the human prostate. Magn Reson Med 2004; 52:80-88
9. Tran TK, Vigneron DB, Sailasuta N, et al. Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer. Magn Reson Med 2000; 43:23-33
10. Cunningham CH, Vigneron DB, Marjanska M, et al. Sequence design for magnetic resonance spectroscopic imaging of prostate cancer at 3 T. Magn Reson Med 2005; 53:1033-1039
11. 1H- spectroscopic imaging of the prostate. Invest Radiol 2004; 39:671-680
12. Mulkern RV, Bowers JL. Calculating spectral modulations of AB systems during PRESS acquisitions. Magn Reson Med 1993; 30:518
13. 1H-MR spectroscopic imaging of the human prostate at 3T. Magn Reson Med 2005; 53:1268-1274
14. Chen AP, Cunningham CH, Ozturk-Isik E, et al. High-speed 3T MR spectroscopic imaging of prostate with flyback echo-planar encoding. J Magn Reson Imaging 2007; 25:1288-1292
15. Cunningham CH, Vigneron DB, Chen AP, et al. Design of symmetric-sweep spectral-spatial RF pulses for spectral editing. Magn Reson Med 2004; 52:147-153
16. Schricker AA, Pauly JM, Kurhanewicz J, Swanson MG, Vigneron DB. Dualband spectral-spatial RF pulses for prostate MR spectroscopic imaging. Magn Reson Med 2001; 46:1079-1087
17. Tran TKC, Vigneron DB, Sailasuta N, et al. Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer. J Magn Reson Imaging 2000; 43:23-33.
18. Mescher M, Merkle H, Kirsch J, Garwood M, Gruetter R. Simultaneous in vivo spectral editing and water suppression. NMR Biomed 1998; 11:266-272
19. Star-Lack J, Nelson SJ, Kurhanewicz J, Huang LR, Vigneron DB. Improved water and lipid suppression for 3D PRESS CSI using RF band selective inversion with gradient dephasing (BASING). Magn Reson Med 1997; 38:311-321
20. Costello LC, Franklin RB. Concepts of citrate production and secretion by prostate. Part 1. Metabolic relationships. Prostate 1991; 18:25-46
21. Mulkern RV, Bowers JL, Peled S, Kraft RA, Williamson DS. Citrate signal enhancement with a homonuclear J-refocusing modification to double-echo PRESS sequences. Magn Reson Med 1996; 36:775-780
22. van der Graaf M, Jager GJ, Heerschap A. Removal of the outer lines of the citrate multiplet in proton magnetic resonance spectra of the prostatic gland by accurate timing of a point-resolved spectroscopy pulse sequence. MAGMA 1997; 5:65-69
23. Heerschap A, Jager GJ, van der Graaf M, et al. In vivo proton MR spectroscopy reveals altered metabolite content in malignant prostate tissue. Anticancer Res 1997; 17:1455-1460
24. Kurhanewicz J, Swanson MG, Nelson SJ, Vigneron DB. Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer. J Magn Reson Imaging 2002; 16:451-463
25. Derby K, Hawryszko C, Tropp J. Baseline deconvolution, phase correction, and signal quantification in Fourier localized spectroscopic imaging. Magn Reson Med 1989; 12:235-240
26. Spielman D, Webb P, Macovski A. Water referencing for spectroscopic imaging. Magn Reson Med 1989; 12:38-49
27. Coakley FV, Kurhanewicz J, Qayyum A. Prostate. In: Edelman RR, Hesselink JR, Zlatkin MB, Crues JV, eds. Clinical magnetic resonance imaging. Philadelphia, PA: Elsevier, 2006:2906-2931
28. Jung JA, Coakley FV, Vigneron DB, et al. Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system. Radiology 2004; 233:701-708
29. Fütterer JJ, Scheenen TW, Heijmink SW, et al. Standardized threshold approach using three-dimensional proton magnetic resonance spectroscopic imaging in prostate cancer localization of the entire prostate. Invest Radiol 2007; 42:116-122
30. Scheenen TW, Heijmink SW, Roell SA, et al. Three-dimensional proton MR spectroscopy of human prostate at 3 T without endorectal coil: feasibility. Radiology 2007; 245:507-516
31. Kurhanewicz J, Vigneron DB. Advances in MR spectroscopy of the prostate. Magn Reson Imaging Clin N Am 2008; 16:697-710
32. Engelhard K, Hollenbach HP, Deimling M, Kreckel M, Riedl C. Combination of signal intensity measurements of lesions in the peripheral zone of prostate with MRI and serum PSA level for differentiating benign disease from prostate cancer. Eur Radiol 2000; 10:1947-1953
33. van Dorsten FA, van der Graaf M, Engelbrecht MR, et al. Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer. J Magn Reson Imaging 2004; 20:279-287
34. 1H MR spectroscopic imaging - initial results. Radiology 2003; 229:241-247
35. Westphalen AC, Coakley FV, Kurhanewicz J, Reed G, Wang ZJ, Simko JP. Mucinous adenocarcinoma of the prostate: MRI and MR spectroscopy features. AJR 2009; 193:870; [web]W238-W243